SEC Form 4 · accession 0001225208-19-004345
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Fitzgerald
Officer — EVP & President, Rhythm Mgmt
Period of report
Mar 3, 2019
Accepted (ET)
Mar 4, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 3, 2019 | M | 3,603 | $0.00 | A | 229,511 | D | |
| Common Stock | Mar 3, 2019 | F | 1,643 | $40.75 | D | 227,868 | D | |
| Common StockF2 | holding | — | — | — | 68,420 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F3 | — | Mar 3, 2019 | M | 3,603 | D | — | Mar 3, 2022 | Common Stock | 3,603 | 10,809 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
- F3Shares of common stock will be issued to the reporting person in five equal annual installments beginning on March 3, 2018, the first anniversary of the date of grant.